Multimodality treatment for locally advanced esophageal cancers

Multimodality treatment in locally advanced non-small cell lung cancer.

Prognosis in patients with locally advanced non-small cell lung cancer (NSCLC) is poor (five year survival rate of 5% [1]). Radiotherapy (RT), chemotherapy (CT) and surgery (S), as single modality therapeutical approaches are unable to eradicate locoregional disease and to control systemic microscopic disease. Concurrent chemoradiation (CTRT) is at present time deemed to be the standard of care...

Locally Advanced Esophageal Cancer

Preoperative treatment of locally advanced esophageal carcinoma (Review).

Esophageal cancer (EC) is an aggressive malignancy with increasing incidence worldwide. Surgery is still the most effective treatment, however, both the high rate of local and distant recurrences and surgery-related complications led us to investigate new preoperative strategies. In this review, we discuss the role of neoadjuvant therapy for locally advanced EC with a focus on preoperative chem...

Aggressive multimodality treatment for advanced rectal cancer.

A case of advanced rectal cancer treated by aggressive local and systemic treatment who has survived more than 7 years from initial recurrence is presented. A 55-year-old woman was diagnosed with advanced lower rectal cancer and underwent a low anterior resection with complete removal of all regional lymph nodes and total mesorectal excision. The tumor was diagnosed as a moderately differentiat...

Intra-arterial infusion chemotherapy in the multimodality treatment for locally advanced buccal cancer in Taiwan

1 Department of Radiation Oncology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan 2 Department of Radiation Oncology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. 3 Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. 4 Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan 5 Departmen...